STAT3 Association with Microtubules and Its Activation Are Independent of HDAC6 Activity

被引:17
|
作者
Yan, Bing [1 ]
Xie, Songbo [1 ]
Liu, Zhu [2 ]
Luo, Youguang [1 ]
Zhou, Jun [1 ]
Li, Dengwen [1 ]
Liu, Min [2 ]
机构
[1] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China
[2] Tianjin Med Univ, Sch Basic Med Sci, Key Lab Immune Microenvironm & Dis, Minist Educ, Tianjin 300070, Peoples R China
基金
中国国家自然科学基金;
关键词
EPIDERMAL-GROWTH-FACTOR; SIGNAL TRANSDUCER; BINDING PROTEIN; DYNAMICS; APOPTOSIS; TRANSPORT;
D O I
10.1089/dna.2014.2713
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Signal transducer and activator of transcription 3 (STAT3) is an important oncogenic transcription factor residing in the cytoplasm in the resting cells. Upon stimulation, STAT3 is activated and translocated to the nucleus to regulate target genes. Although the canonical transcriptional function of STAT3 has been intensively studied, less is known about its cytoplasmic localization. In this study, by immunoprecipitation, microtubule cosedimentation, and immunofluorescence assays, we present the first evidence that cytoplasmic STAT3 interacts with both tubulin and microtubules. By using small-molecule inhibitor approaches, we further demonstrate that the localization of STAT3 on microtubules and its activation are independent of histone deacetylase 6 (HDAC6) activity. In addition, disruption of microtubule dynamics does not alter the activation and nuclear translocation of STAT3 in response to interleukin-6 treatment. These findings reveal that cytoplasmic STAT3 is physically associated with microtubules, whereas its activation and nuclear translocation are independent of microtubule dynamics, implicating that the association of STAT3 with microtubules might be involved in the regulation of noncanonical functions of STAT3 in the cytoplasm.
引用
收藏
页码:290 / 295
页数:6
相关论文
共 50 条
  • [21] Inhibition of HDAC6 Activity Protects Against Endothelial Dysfunction and Atherogenesis in vivo: A Role for HDAC6 Neddylation
    Nomura, Yohei
    Nakano, Mitsunori
    Woo Sung, Hyun
    Han, Mingming
    Pandey, Deepesh
    FRONTIERS IN PHYSIOLOGY, 2021, 12
  • [22] Alternative HDAC3 and HDAC6 deacylase activities and the structural activity relationship of a selective HDAC3 inhibitor
    Zhang, Cheng
    Inks, Elizabeth
    McClure, Jesse
    Chou, C. James
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [23] MOMELOTINIB AND CITARINOSTAT: CO-TARGETING JAK2/STAT3 AND HDAC6 IN LYMPHOID MALIGNANCIES, A NEW POTENTIAL THERAPEUTIC COMBINATION
    Cosenza, M.
    Civallero, M.
    Sacchi, S.
    Pozzi, S.
    HAEMATOLOGICA, 2018, 103 : S118 - S119
  • [24] Momelotinib and Citarinostat: Co-Targeting JAK2/STAT3 and HDAC6 in Lymphoid Malignancies, a New Potential Therapeutic Combination
    Cosenza, Maria
    Civallero, Monica
    Sacchi, Stefano
    Pozzi, Samantha
    BLOOD, 2017, 130
  • [25] Inhibition of Histone Deacetylase 6 (HDAC6) Disrupts the Tolerogenic STAT3 Signaling Pathway and Augments Antitumor Immune Responses in Mantle Cell Lymphoma (MCL)
    Wang, Hongwei
    Cheng, Fengdong
    Wang, Zi
    Lienlaf, Maritza
    Perez-Villarroel, Patricio
    Knox, Tessa
    Sahakian, Eva
    Pinilla-Ibarz, Javier
    Horna, Pedro
    Chen-Kiang, Selina
    Martin, Peter
    Bergman, Joel
    Kozikowski, Alan
    Villagra, Alejandro
    Tao, Jianguo
    Shah, Bijal D.
    Sotomayor, Eduardo M.
    BLOOD, 2012, 120 (21)
  • [26] HDAC6 mediates NLRP3 inflammasome activation in the pathogenesis of diabetic retinopathy
    Kim, Jun-Sik
    Jun, Jae Hyun
    Lee, Jeongmi
    Park, Sunyoung
    Kim, Eunae
    Hwang, Su Jung
    Moon, Heesu
    Baek, Seung Hyun
    Kim, Hark Kyun
    Park, Jinsu
    Cho, Yoonsuk
    Han, Jihoon
    Kim, Chanhee
    Kim, Jongho
    Yang, Hyun-Mo
    Lee, Changsik
    Chung, Yeonseok
    Lee, Hyo-Jong
    Jo, Dong-Gyu
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2025, 164
  • [27] Association of early phase of colorectal carcinogenesis with STAT3 activation and its relevance in apoptosis regulation
    Baral, Rathindranath
    Bose, Anamika
    Ray, Chinmoyee
    Paul, Sonali
    Pal, Smarajit
    Haque, Enamul
    Mishra, Bhagawan
    Pal, Debolina
    Nagpal, Jatin Kumar
    Panda, Chinmay Kumar
    Das, Bibhu Ranjan
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2009, 87 (01) : 36 - 41
  • [28] Inhibition of HDAC6 activity through interaction with RanBPM and its associated CTLH complex
    Salemi, Louisa M.
    Maitland, Matthew E. R.
    Yefet, Eyal R.
    Schild-Poulter, Caroline
    BMC CANCER, 2017, 17
  • [29] Inhibition of HDAC6 activity through interaction with RanBPM and its associated CTLH complex
    Louisa M. Salemi
    Matthew E. R. Maitland
    Eyal R. Yefet
    Caroline Schild-Poulter
    BMC Cancer, 17
  • [30] Activation of STAT1 increases necrosis and apoptosis following ischemia/reperfusion independent of STAT3 activation
    Illigens, BM
    Hsieh, YJ
    Cowan, DB
    McGowan, FX
    Levitsky, S
    McCully, JD
    CIRCULATION, 2004, 110 (17) : 506 - 506